Clinical Chemistry, Malmö
1111 – 1120 of 1295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections
(
- Contribution to journal › Article
-
Mark
Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2
(
- Contribution to journal › Article
-
Mark
Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia
(
- Contribution to journal › Article
-
Mark
Rationale for randomised trials of prostate cancer screening
(
- Contribution to journal › Scientific review
-
Mark
Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancer
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
(
- Contribution to journal › Article
-
Mark
Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling
(
- Contribution to journal › Article
-
Mark
Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C
(
- Contribution to journal › Article
-
Mark
Calcium binding to the first EGF-like module of human factor IX in a recombinant fragment containing residues 1-85. Mutations V46E and Q50E each manifest a negligible increase in calcium affinity
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance in patients with peripheral vascular disease
(
- Contribution to journal › Article